Webinars | Page 2 | Aplastic Anemia & MDS International Foundation

Webinars

Hero Image

Rare blood cancer and bone marrow failure diseases are often difficult to diagnose and even harder to explain. AAMDSIF brings international experts to your computer, tablet or smartphone using language that is easy to understand in a convenient one hour format. We have hundreds of webinars available for you to watch at any time you want!

Register for Upcoming 2020 Patient Webinars

Watch Recorded Patient Webinars

Presenter: Eytan Stein, MD
Topic(s): Pediatric Bone Marrow Failure Diseases, Myelodysplastic Syndromes (MDS)

Eytan M. Stein, MD is a Oncologic Hematologist at Sloan Kettering emorial Cancer Center who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. He earned his medical degree from Northwestern University and is board certified in Internal Medicine, Medical Oncology, and Hematology. Dr. Stein is an active clinical researcher developing new and innovative approaches to treating acute myeloid leukemia (AML) and serves as the principal investigator on a wide variety of clinical trials. 

In this webinar, Dr. Eytan M. Stein discusses the important issues specific to young adults with MDS, from long-term prognosis and fertility concerns to next generation sequencing and clinical trial opportunities.
Presenter: Ryotaro Nakamura, MD
Topic(s): Bone Marrow Transplant, Aplastic Anemia, Myelodysplastic Syndromes (MDS)

Ryotaro Nakamura, MD is Professor, Department of Hematology & Hematopoietic Cell Transplantation; Director, Center for Stem Cell Transplantation at City of Hope. 

Dr. Nakamura discusses the how the best practices for treating aplastic anemia and MDS have changed to include transplant as a realistic option for many patients over 40.  With new conditioning regimes and improved matching, many patients can have a successful transplant well into their 70s.  Dr. Nakamura also gives an overview of how aplastic anemia and MDS affect the bone marrow, a critical part of the decisionmaking process for determining if a transplant is an option.  
 

Presenter: Bhumika Patel, MD
Topic(s): Aplastic Anemia, Living Well with Bone Marrow Failure

Bhumika Patel, MD, is a board certified hematologist/oncologist who was appointed to the Cleveland Clinic Taussig Cancer Center in 2019, following two successful fellowships.  Dr. Patel is an active researcher, contributing to more than 40 studies over the last three years with a focus on bone marrow failure diseases.

In this webinar, Dr. Patel discusses the specific concerns of women living with aplastic anemia, from the newly diagnosed to longer-term survivors and includes a robust Q & A sessions with input from women living with aplastic anemia. 

Presenter: Vijaya Bhatt, MD
Topic(s): Bone Marrow Transplant

Dr. Bhatt and Dr. Zimmer discuss important information about how and when to treat infectious disease in patients who have had a transplant. This webinar is appropriate for patients who are contemplating a transplant and those who have already had one. 

Vijaya R. Bhatt, MD, MBBS, is Assistant Professor, Internal Medicine in the Division of Oncology & Hematology and the University of Nebraska Medical Center. Dr. Bhatt sees patients at the Fred & Pamela Buffett Cancer Center where he specializes in hematopoietic stem cell transplant, post-transplant complications, graft-versus-host disease, leukemias, myeloid disorders and benign hematologic disorders. 

Dr. Bhatt is board certified in Hematology and Medical Oncology as well as being a well-regarded researcher.  He has published numerous journal articles, papers and analyses on topics including the treatment of infectious disease in transplant patients. 

Andrea Zimmer, MD, joins the webinar to provide her perspective in infection diseases. Dr. Zimmer is Assistant Professor, Department of Internal Medicine, Co-Director, Graduate Medical Education Curriculum, Microbiology & Infectious Diseases Block at the University of Nebraska School of Medicine.  Dr. Zimmer treats patients at the Fred & Pamela Buffett Cancer Center, providing guidance and support to patients and health care professionals in managing the risks of infectious disease.

Presenter: Tiffany Tanaka, MD
Topic(s): Aplastic Anemia, Myelodysplastic Syndromes (MDS)

Tiffany N. Tanaka, MD, is a board-certified hematologist specializing in the diagnosis and treatment of blood cancers and blood disorders, with an emphasis on myeloid malignancies.  Dr. Tanaka provides an overview of the diagnostic and treatment considerations for patients who have aplastic anemia and hypoplastic MDS.  This overlapping set of bone marrow failure diseases raises critical questions for patients and health care professionals. 

Presenter: Holly Comer, BSN, ANP-BC
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, Living Well with Bone Marrow Failure, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Holly Comer, BSN, ANP-BC, has been an oncology nurse for 30 years and has been a nurse practitioner for the last 14 years.  Ms. Comer is with Siteman Cancer Center at Barnes-Jewish Hospital & Washington University School of Medicine where she has been part of the Bone Marrow Transplant team for the last 26 years. She also served as a nurse during the Gulf War. Ms. Comer is actively involved in clinical research, most recently serving as the principal investigator for "Bone Loss in Allogeneic Transplant Patients", the results of which will be covered during her webinar. 

Holly Comer, MSN, ANP-BC provides a thorough overview of the concerns of long term transplant survivors related to bone health and disease. Ms. Comer also provides an update on a recent study she led entitled "Bone Loss in Allogenic Transplant Patients".

Presenter:
Topic(s): Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Kathleen Moore, MD is Director, Oklahoma TSET Phase I Program; Associate Professor, Section of Gynecologic Oncology and is an associate professor in the section of gynecologic oncology and serves as the director of the Oklahoma TSET Phase I Clinical Trials Program, the state’s only phase I clinical trials program. She is the Jim and Christy Everest Endowed Chair in Cancer Research as well as the director of the gynecologic oncology fellowship program. She also serves as the Associate Director of Clinical Research and Medical Director of the Clinical Trials Office for the Stephenson Cancer Center. 

Dr. Moore discusses the unique concerns of female patients who develop Secondary MDS/AML after chemotherapy treatment.  This session includes current treatment options as well as a review of what is currently in clinical trial, including Dr. Moore's own work in drug development. 

Presenter: Carlos E. Vigil, MD
Topic(s): Myelodysplastic Syndromes (MDS)

Carlos E. Vigil, MD is a Hematologist at the University of Iowa Hospitals and Clinics and Clinical Assistant Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation at the University of Iowa Carver College of Medicine. Dr. Vigil received his MD from the Universidad Peruana Cayetano Heredia and is engaged in academic research as well as working directly with patients in clinic.

Dr. Vigil discusses autoimmune disorders and MDS (myelodysplastic syndromes) including an assessment of the overlap between autoimmune disorders and bone marrow failure disease, the impact this can have on treatment options and on patient prognosis.

Presenter:
Topic(s): Aplastic Anemia

Swapna Thota, MD joined Roswell Park in 2017 where she specializes in caring for patients with acute leukemias, MDS and other blood cancers. She holds a dual appointment as Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center and Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo.  Dr. Thota's research focuses on hematologic malignancies, especially on novel drug development to improve outcomes in patients with blood cancers. 

Dr. Thota discusses the complexities of determining the best course of treatment for patients with moderate aplastic anemia

Presenter: Shannon McCurdy, MD
Topic(s): Myelodysplastic Syndromes (MDS)

Dr. McCurdy discusses treating MDS (myelodysplastic syndromes) with combination therapies including the latest treatment options available and promising clinical trials and research.

Presenter: Bhavisha Patel, MD
Topic(s): Aplastic Anemia

Dr Patel of the National Institutes of Health Bhavisha Patel, MD, is a Staff Clinician at the National Institutes of Health, working under Neal Young, MD on the Hematopoiesis and Bone Marrow Failure team.

Presenter: Sarah Bannon, MS, CGC
Topic(s): Myelodysplastic Syndromes (MDS)

Sarah Bannon is a Senior Genetic Counselor in the Department of Clinical Cancer Genetics at the UT MD Anderson Cancer Center. Her clinical responsibilities include providing risk assessment and genetic counseling services to individuals at risk for an inherited predisposition to hematologic malignancies (leukemia). She is the Genetic Counselor for the Hereditary Hematologic Malignancies Clinic (HHMC).

In this webinar, Ms. Bannon discusses hereditary or genetic predisposition to having MDS.

Presenter: Mary K. Hughes, MS, RN, CNS, CT
Topic(s): Living Well with Bone Marrow Failure, Managing Your Treatment

Mary Hughes, MS, RN, CNS, CT shares coping strategies that patients can use to lessen the fear of disease recurrence as they adjust to life after diagnosis and treatment.

Presenter: Olatoyosi Odenike, MD
Topic(s): COVID-19

Olatoyosi Sobulo Odenike, MD, is Professor of Medicine in the Section of Hematology/Oncology and Director of the Leukemia Program at the University of Chicago as well as Co-Chair of the AAMDSIF Medical Advisory Board. Dr. Odenike is an expert in the care of adults with leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes. An active researcher, Dr. Odenike is involved in the development of novel therapeutic agents for the treatment of acute and chronic leukemias and chronic myeloproliferative diseases. The ultimate goal of her research is to improve treatment options for patients with these diseases. Dr. Odenike is the principal investigator on a number of clinical trials investigating molecularly targeted agents in this patient population. These clinical trials also integrate laboratory studies to evaluate the effect that these agents have on cancer cells.

Presenter: Krisstina Gowin, DO
Topic(s): Living Well with Bone Marrow Failure

Dr. Gowin discusses the critical aspects of living well with the overlapping diagnosis of MDS and MPNs. Her presentation includes a scientific assessment of interventions including nutrition, supplements, exercise and meditation.

Presenter: Timothy Olson, MD, PhD
Topic(s): Aplastic Anemia

Due to internet connectivity issues, the audio for this webinar will be rerecorded as soon as the speaker is available. In the interim, please accept our apologies for the quality of the sound. We are attached a PDF of the presentation for your review although we note that the video quality was acceptable. 

Timothy S. Olson, MD, PhD, is an Attending Physician with Children's Hospital of Philadelphia where he serves as the Medical Director of the Blood and Bone Marrow Transplant Program and as Director of Research for the Comprehensive Bone Marrow Failure Center.  Dr. Olson is also an Assistant Professor of Pediatrics at the Perelman School of Medicine at The University of Pennsylvania.  Dr. Olson focuses on pediatric hematopoietic stem cell transplantation (HSCT), with a specific emphasis on HSCT for patients with inherited and acquired bone marrow failure.

Presenter: Michael Keng, MD
Topic(s): Myelodysplastic Syndromes (MDS)

Michael Keng, M.D. is an Assistant Professor and holds a clinical faculty appointment in Medicine in the Division of Hematology/Oncology at UVA Cancer Center. He practices at the Emily Couric Clinical Cancer Center in Charlottesville and serves as an inpatient hematologist at UVA Hospital. His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoid leukemia, and aplastic anemia. Dr. Keng provides a overview of the current treatment strategies for high risk MDS (myelodysplastic syndromes) patients and answers patient questions at the end of the presentation. Please note that this presentation is runs longer than most AAMDSIF webinars (1 hour, 27 minutes).

Presenter: Ilene Weitz, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia

Ilene Weitz, MD, is an assistant professor of clinical medicine at the Keck School of Medicine at the University of Southern California (USC). Her practice sites include, LAC+USC Medical Center, Keck Hospital of USC and USC Norris Cancer Hospital. Dr. Weitz is board certified in Internal Medicine and Hematology.  This webinar focuses on the latest in research presented at the 2019 American Society of Hematology (ASH) Annual Meeting held at the end of 2019. Dr. Weitz has selected a number of abstracts (research summaries) and provides a high level assessment of new and ongoing research into treating aplastic anemia and/or PNH. Participants were able to submit questions during the presentation and Dr. Weitz' responses are at the end of the webinar recording. 

Presenter: Mikkael Sekeres, MD, MS
Topic(s): COVID-19

Mikkael Sekeres, MD, MS discusses issues related to the impact of COVID-19 on the care of bone marrow failure patients including the importance of patients remaining at home even as more areas reduce restrictions, adapting to telemedicine, and resuming treatments that may have been delayed.

Filter by keyword, presenter name, etc.
Presenter: Phil Scheinberg, MD
Topic(s): Aplastic Anemia

During this webinar, Dr. Phillip Scheinberg from Hospital Sao Jose, Beneficencia Portuguesa de Sao Paolo in Brazil discusses the history of Aplastic Anemia - past, current and future thinking of the disease and treatment options.

Presenter: Casey O'Connell, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, Living Well with Bone Marrow Failure, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

In the webinar, Dr. Casey O'Connell from USC Norris Comprehensive Cancer Center helps patients understand the most commonly used lab tests to diagnosis and monitor bone marrow failure diseases.

Presenter: Kasiani Myers, MD
Topic(s): Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia

Dr. Kasiani Myers of The Cancer and Blood Diseases Institute in Cincinnati, OH discusses the causes, diagnosis, and treatment of aplastic anemia and PNH. She will also discuss the relationship between aplastic anemia and PNH and how the dual diagnosis is treated.

Presenter: Jaroslaw Maciejewski, MD, PhD, Bhumika Patel, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia

During this program, Dr. Bhumika Patel and Dr. Jaroslaw Maciejewski from Taussig Cancer Institute discuss research reported over the past year on the biology and treatment of aplastic anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2018 meeting in San Diego, CA. Research findings are explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH.

Presenter: Shyamala Navada, MD
Topic(s): Aplastic Anemia, Myelodysplastic Syndromes (MDS)

Dr Navada explains how healthcare professionals diagnosis and treat the overlapping conditions of aplastic anemia and MDS, outlining the decisionmaking process and key factors relevant to effective treatment. 

Presenter: Amir Fathi, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

This webinar explains how myeloid malignancies form in plain language for patients and families. 

Presenter: Amy E. DeZern, MD, MHS
Topic(s): Aplastic Anemia

Dr DeZern provides a thorough review of the three major classificiations of aplastic anemia including diagnosis, treatment and prognosis. 

Presenter: Cecelia Arana Li, MD
Topic(s): Aplastic Anemia

Dr Arana Yi provides a thorough overview of aplastic anemia including a discussion of the diagnosis and treatment options currently available. 

Presenter: David Margolis, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia

This webinar discusses the most recent findings in aplastic anemia and PNH from the American Society of Hematology 2017.  

Filter by keyword, presenter name, etc.
Presenter: Ruben Mesa, MD, FACP
Topic(s): COVID-19, Myelodysplastic Syndromes (MDS)

Dr. Mesa discusses the overlap between MDS (myelodysplastic sydromes) and MPNs (myeloproliferative neoplasms), including diagnosis and treatment options including the latest in clinical trials. He also provides an update on the impact of COVID-19 on patients with MDS/MPNs overlap syndrome.

Presenter: Ruben Mesa, MD, FACP
Topic(s): COVID-19, Myelodysplastic Syndromes (MDS)

This webinar is an excerpt from a longer webinar entitled "Understanding the Overlap between MDS and MPNs" and has been edited accordingly. Dr. Mesa gives an overview of the specific concerns that patients with the overlapping conditions of MDS and MPNs have related to the coronavirus (COVID-19) pandemic. 

Presenter: Rami Komrokji, MD
Topic(s): COVID-19, Myelodysplastic Syndromes (MDS)

Rami Komrokji, MD, of Moffitt Cancer Center in Tampa, Florida, addresses the concerns of low-risk MDS patients and their caregivers and reviews the precautions they should be taking to protect their health during the COVID-19 pandemic. The webinar recording features patient-submitted questions.

Presenter: Daniel Pollyea, MD, MS
Topic(s): Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)

Daniel Pollyea, MD, MS, University of Colorado Health, gives a comprehensive overview of what happens when a higher risk MDS patient transitions to AML including the diagnositic criteria, treatment options and outcomes assessments. Dr. Pollyea also reviews some of the most promising treatment options that are in clinical trial and/or new to the treatment space. He also discusses the increasing success rates for older patients who go to transplant as a curative treatment for High Risk MDS and AML. Dr. Pollyea answers a number of patient-submitted questions as well. 

Presenter: Rami Komrokji, MD
Topic(s): Myelodysplastic Syndromes (MDS)

Rami Komrokji, MD, Moffitt Cancer Center, Florida, provides a comprehensive overview of lower risk MDS from diagnosis to treatment. Dr. Komrokji focuses on how hematologists and oncologists use different tools to assess the risk for patients when diagnosed with MDS including an overview of IPSS-R. He also explains how this assessment tool is only useful prior to treatment and that after interventions, other assessment tools are used by healthcare professionals to provide guidance and support to patients, families and caregivers. Dr. Komrokhi further discusses the treatment landscape including the newly announced luspatercept and several prospective treatments in the pipeline/clinical trial phase. 

Presenter: Timothy Pearman, PhD, Jenny Finkel
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, COVID-19, Living Well with Bone Marrow Failure, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

The COVID-19 pandemic has brought many changes to how  we live our lives,. It has brought uncertainty, altered daily routines, financial pressures, and social isolation.

In this webinar, Dr. Timothy Pearman from Northwestern University Feinberg School of Medicine and Jenny Finkel from Jenny Finkel Yoga discuss self-care strategies for patients, families and caregivers which can improve emotional health and wellness and empower participants during this difficult time. Jenny and Dr. Pearman also demonstrate accessible yoga practices which you can do at home to help keeping you moving and help relieve stress. 

Presenter: Amer Zeidan, M.D.
Topic(s): Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)

In this webinar, Dr. Amer Zeidan from Yale Cancer Center discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2019 meeting in Orlando, Florida.

Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML.

Presenter: Gail J. Roboz, M.D.
Topic(s): COVID-19, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

This webinar with Gail Roboz, MD, addresses the concerns of high-risk MDS or secondary AML patients and their caregivers and reviews the precautions they should be taking to protect their health. Patients, families and caregiver questions are included at the end of the presentation. 

Presenter: Amy E. DeZern, MD, MHS, Veronica Dioverti, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, COVID-19, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Dr. DeZern and Dr. Dioverti address the concerns of bone marrow failure disease patients and their caregivers and review the precautions they should be taking to protect their health.
They also answer participant questions and answers.

Presenter: Inga Hofmann Zhang, MD, PhD, David Margolis, MD
Topic(s): Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, COVID-19, Myelodysplastic Syndromes (MDS)

Dr. Hofmann and Dr. Margolis will discuss the specific concerns related to COVID-19 for pediatric bone marrow failure patients and their parents, including pre- and post-transplant issues.   

There will be an opportunity for questions and answers via the webinar platform. 

Presenter: Catherine Lai, MD, MPH
Topic(s): Myelodysplastic Syndromes (MDS)

Dr Catherine Lai, Medstar Georgetown University Hospital Lombardi Comprehensive Cancer Center, discusses the challenges associated with treating MDS in older adults and what treatment options are available. 

Presenter: Gail J. Roboz, M.D.
Topic(s): Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Dr. Gail Roboz from Weill Cornell, discusses the advances in MDS and AML research that was reported at the annual conferences of two major hematology/oncology organizations this summer – the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA).

Presenter: Pamela Becker, MD, PhD
Topic(s): Myelodysplastic Syndromes (MDS)

During this webinar, Dr. Pamela Becker from Seattle Cancer Care Alliance and University of Washington School of Medicine discusses the history of MDS - past, current and future thinking of the disease and treatment options.

Presenter: Marlise Luskin, MD, MSCE
Topic(s): Myelodysplastic Syndromes (MDS)

Dr. Marlise Luskin from Dana Farber Cancer Institute defines high-risk MDS versus low-risk MDS, impact for patients and what treatment options are available.

Presenter: Casey O'Connell, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Bone Marrow Transplant, Aplastic Anemia, Living Well with Bone Marrow Failure, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

In the webinar, Dr. Casey O'Connell from USC Norris Comprehensive Cancer Center helps patients understand the most commonly used lab tests to diagnosis and monitor bone marrow failure diseases.

Presenter: Amer Zeidan, M.D.
Topic(s): Myelodysplastic Syndromes (MDS)

Dr. Amer Zeidan from Yale Cancer Center explains the different mutations found in MDS and answers the question -“Should patients with MDS ask about their cancer mutations?” He discusses how mutations impact prognosis and affect treatment decisions

Presenter: Matt Kalaycio, MD
Topic(s): Bone Marrow Transplant, Myelodysplastic Syndromes (MDS)

In this webinar, Dr. Matt Kalaycio explains what is a bone marrow transplant and the risk and benefits of a transplant for MDS patients. Patients will be able to use the information learned in this webinar to have a discussion with their treating physician if a transplant is right for them.

Presenter: Sudipto Mukherjee, MD, MPH
Topic(s): Myelodysplastic Syndromes (MDS)

Updates from the December 2018 convening of the America Society of Hematology on MDS. 

Presenter: Joshua Sasine, MD, PhD
Topic(s): Bone Marrow Transplant, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Joshua Sasine, MD, PhD discusses CAR-T cells and how they are used in transplant.  

Presenter: Shyamala Navada, MD
Topic(s): Aplastic Anemia, Myelodysplastic Syndromes (MDS)

Dr Navada explains how healthcare professionals diagnosis and treat the overlapping conditions of aplastic anemia and MDS, outlining the decisionmaking process and key factors relevant to effective treatment. 

Filter by keyword, presenter name, etc.
Presenter: Amir Fathi, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

This webinar explains how myeloid malignancies form in plain language for patients and families. 

Presenter: Elizabeth Griffiths, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH)

A look to the future of treatment for patients with PNH (paroxysmal nocturnal hemoglobinuria). 

Presenter:
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH)

This webinar discusses issues related to PNH. 

Presenter: Catherine Broome, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH)

Dr Catherine Broome provides a comprehensive overview of PNH for newly diagnosed patients and their families. This is a recorded webinar so you will not be able to ask questions. If you do have questions, please send an email to help@aamds.org or use the Chat option on the bottom right of your screen. 

Presenter: David Margolis, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia

This webinar discusses the most recent findings in aplastic anemia and PNH from the American Society of Hematology 2017.  

Presenter: Leslie Ellis, BS, MD
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH)

Learn about PNH, or Paroxysmal Nocturnal Hemoglobinuria. Dr. Leslie Ellis presents from normal bone marrow and blood to the PNH issues and diagnosis. Participants asked questions. 

 

Filter by keyword, presenter name, etc.

No matching recorded webinars found.

If you are using "search terms", try simplifying or removing them.

Filter by keyword, presenter name, etc.
Presenter: Daniel Pollyea, MD, MS
Topic(s): Acute Myeloid Leukemia (AML)

In this webinar, Dr. Daniel Pollyea from the University of Colorado, discusses the recent advances in treating AML.

Presenter: Thomas LeBlanc, MD, MA
Topic(s): Acute Myeloid Leukemia (AML)

In this webinar, Dr. Thomas LeBlanc from Duke University Hospital discusses AML - how the diagnosis and treatment decisions impact patients. He provides a basic overview of AML and current treatments.

Presenter: Joshua Sasine, MD, PhD
Topic(s): Bone Marrow Transplant, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Joshua Sasine, MD, PhD discusses CAR-T cells and how they are used in transplant.  

Presenter: Amir Fathi, MD
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Pediatric Bone Marrow Failure Diseases, Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Myelodysplastic Syndromes (MDS), Managing Your Treatment, Acute Myeloid Leukemia (AML)

This webinar explains how myeloid malignancies form in plain language for patients and families. 

Presenter:
Topic(s): Pediatric Bone Marrow Failure Diseases, Acute Myeloid Leukemia (AML)

This webinar discusses the diagnosis and treatment options for pedaitric AML patients and their families. 

Presenter: Ryan J. Mattison, MD
Topic(s): Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Dr Mattison provides an overview of the two primary diagnosis tools for patients with MDS (myelodysplatic syndromes).  

Presenter: Michael Savona, MD
Topic(s): Acute Myeloid Leukemia (AML)

Dr Savona explains what options are available for patients with AML outside of transplant. 

Presenter: Jacqueline Garcia, MD
Topic(s): Acute Myeloid Leukemia (AML)

Dr. Jacqueline Garcia describes diagnostic and therapeutic options for AML, or Acute Myeloid Leukemia.

Filter by keyword, presenter name, etc.

No matching recorded webinars found.

If you are using "search terms", try simplifying or removing them.

Filter by keyword, presenter name, etc.
Presenter: Joshua Sasine, MD, PhD
Topic(s): Bone Marrow Transplant, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

Joshua Sasine, MD, PhD discusses CAR-T cells and how they are used in transplant.  

Presenter:
Topic(s): Bone Marrow Transplant

Steven Devine, MD walks potential donors through all of the steps to becoming a bone marrow donor from screening to donation and everything in between. This webinar was a joint project between Be the Match and AAMDSIF. 

Presenter:
Topic(s): Bone Marrow Transplant

Dr Malone explains the key issues for transplant patients during the first 100 days, focusing on Acute GVHD (graft-versus-host-disease). 

Filter by keyword, presenter name, etc.

No matching recorded webinars found.

If you are using "search terms", try simplifying or removing them.

Filter by keyword, presenter name, etc.

No matching recorded webinars found.

If you are using "search terms", try simplifying or removing them.

Filter by keyword, presenter name, etc.

No matching recorded webinars found.

If you are using "search terms", try simplifying or removing them.